LOXL2, Recombinant, Human (Lysyl Oxidase-like Protein 2, Lysyl Oxidase Related Protein 2, LOR2, Lysyl Oxidase Homolog 2, Lysyl Oxidase Related Protein WS9-14)

Lysyl Oxidase Homolog 2 (lysyl oxidase-like protein 2, LOXL2) is a member of lysyl oxidase-like (LOXL) gene family which includes LOXL1 through LOXL4. These enzymes are secreted copper-binding amine oxidases that oxidize primary amine substrates to aldehydes. The N-terminal region of LOXL2 contains four scavenger receptor cysteine- rich (SRCR) domains, and the C-terminal region is a catalytic domain similar to other lysyl oxidases. The catalytic domain contains conserved residues required for copper binding and formation of a lysyl tyrosylquinone co-factor. Although some of the LOXL enzymes are known to cross-link collagen and elastin substrates, such a function has yet to be characterized for LOXL2. It has been shown that LOXL2 promotes cell migration and tumor cell invasiveness. Elevated expression of LOXL2 is also associated with cancer progression in various tumors and carcinoma cell lines, which makes it a potential marker for prognosis of cancer. LOXL2 is expressed in many tissues, with elevated levels in reproductive tissues such as placenta, uterus, and prostate.\n\nSource:\nMurine myeloma cell line, NS0-derived Met1 Gln774, with a C-terminal 10-His tag.\n\nSDS-PAGE: \n100-110kD, reducing conditions\n\nActivity: \nMeasured by its ability to produce to produce hydrogen peroxide during the oxidation of benzylamine.\n\nSpecific Activity:\n(same/more than)2pmoles/min/ug\n\nEndotoxin Level: (same/less than)1EU/1ug (LAL)\n\nStorage and Stability:\nAliquot to avoid repeated freezing and thawing and store at -70 degrees C. Aliquots are stable for at least 6 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

L2623-15A

Size

10ug

Form

Supplied as a liquid in MES, sodium chloride.

Purity

~90% (SDS-PAGE, reducing conditions)

References

1. Csiszar, H. (2001) Prog. Nucleic Acid Res. Mol. Biol. 70:1. 2. Maki, J.M. and K.I. Kivirikko (2001) Biochem J. 355:381. 3. Akiri, G. et al. (2003) Cancer Res. 63:1657. 4. Hollosi, P. et al. (2009) Int. J. Cancer. 125:318. 5. Peinado, H. et al. (2008) Cancer Res. 68:4541. 6. Jourdan